Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SNS-032 + unspecified PD-1 antibody |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SNS-032 | BMS-387032|BMS387032|SNS032 | CDK2 Inhibitor 31 CDK7 Inhibitor 16 CDK9 Inhibitor 21 GSK-3alpha Inhibitor 1 | SNS-032 (BMS-387032) is an inhibitor of CDK2, CDK7, CDK9, and GSK3A, which may promote cell cycle arrest and induction of apoptosis in cancer cells (PMID: 19169685, PMID: 20479412). | |
unspecified PD-1 antibody | Experimental PD-1 antibody | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|